Last $3.14 USD
Change Today +0.01 / 0.32%
Volume 44.9K
ECTE On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

echo therapeutics inc (ECTE) Snapshot

Open
$3.13
Previous Close
$3.13
Day High
$3.20
Day Low
$3.05
52 Week High
04/22/13 - $7.00
52 Week Low
05/10/13 - $1.84
Market Cap
37.6M
Average Volume 10 Days
124.8K
EPS TTM
$-2.95
Shares Outstanding
12.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ECHO THERAPEUTICS INC (ECTE)

Related News

No related news articles were found.

echo therapeutics inc (ECTE) Related Businessweek News

No Related Businessweek News Found

echo therapeutics inc (ECTE) Details

Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital critical care units; and Symphony SkinPrep system, a component of its Symphony for enhanced skin permeation that enables extraction of analytes, such as glucose. The company is also engaged in the development Durhalieve, an AzoneTS formulation of triamcinolone acetonide that has completed Phase III clinical trials for the treatment of corticosteroid-responsive dermatoses. It has a licensing agreement with Ferndale Pharma Group, Inc. to develop, market, sell, and distribute Prelude SkinPrep system for skin preparation prior to the application of topical anesthetics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other portions of the European Community; a license agreement with Handok Pharmaceuticals Co., Ltd. to develop, use, market, import, and sell Symphony for continuous glucose monitoring for use by medical facilities and/or individual consumers in South Korea; and a license, development, and commercialization agreement with Medical Technologies Innovation Asia, Ltd. The company was founded in 1989 and is headquartered in Philadelphia, Pennsylvania.

28 Employees
Last Reported Date: 03/28/14
Founded in 1989

echo therapeutics inc (ECTE) Top Compensated Officers

Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $270.0K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $305.0K
Compensation as of Fiscal Year 2012.

echo therapeutics inc (ECTE) Key Developments

Echo Therapeutics, Inc. Announces Consolidated Earnings Results for the Fourth Quarter Year Ended December 31, 2013

Echo Therapeutics, Inc. announced consolidated earnings results for the fourth quarter year ended December 31, 2013. For the quarter, the company reported total revenue loss of $40,071 against $87,662 a year ago. Loss from operations was $3,119,056 against $4,699,059 a year ago. Net loss was $3,500,630 against $1,926,799 a year ago. Net loss applicable to common shareholders was $3,871,770 against $1,926,799 a year ago. Basic and diluted net loss per common share was $0.36 against $0.48 a year ago. For the year, the company reported total revenues of $27,600 against $5,119 a year ago. Loss from operations was $19,636,468 against $15,040,020 a year ago. Net loss was $3,500,630 against $1,926,799 a year ago. Net loss applicable to common shareholders was $19,067,397 against $12,332,008 a year ago. Basic and diluted net loss per common share was $2.33 against $3.12 a year ago.

Echo Therapeutics, Inc., 2013 Earnings Call, Mar 27, 2014

Echo Therapeutics, Inc., 2013 Earnings Call, Mar 27, 2014

Echo Therapeutics, Inc. to Report Fiscal Year 2013 Results on Mar 27, 2014

Echo Therapeutics, Inc. announced that they will report fiscal year 2013 results on Mar 27, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECTE:US $3.14 USD +0.01

ECTE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $38.38 USD +0.41
Bayer AG €93.22 EUR +0.28
Johnson & Johnson $98.75 USD -0.45
Roche Holding AG SFr.254.90 CHF +0.70
View Industry Companies
 

Industry Analysis

ECTE

Industry Average

Valuation ECTE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,213.3x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,064.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ECHO THERAPEUTICS INC, please visit www.echotx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.